Literature DB >> 22294558

Cost-of-illness studies and cost-effectiveness analyses in eating disorders: a systematic review.

Nina Stuhldreher1, Alexander Konnopka, Beate Wild, Wolfgang Herzog, Stephan Zipfel, Bernd Löwe, Hans-Helmut König.   

Abstract

OBJECTIVE: To review cost-of-illness studies (COIs) and cost-effectiveness analyses (CEAs) of eating disorders (EDs) and to describe their methodological quality.
METHOD: A systematic literature search was done. Search results passed through a selection process, included studies were classified as COIs, CEAs, or "other cost studies" (OCS). Costs were inflated and converted to 2008 US$ purchasing power parities (PPP). Quality criteria were developed and applied to each study.
RESULTS: Five COI, two CEA, and eleven "OCS" were reviewed. Most studies focused on anorexia nervosa and bulimia nervosa. Annual costs per patient ranged from 1,288 to 8,042 US$-PPP. All interventions, investigated in CEA, were more effective and less costly than the alternative treatments. DISCUSSION: The number of publications investigating costs in EDs has increased recently. However, no COI provided a comprehensive estimate of costs, and the comparability of CEA was limited. Nonetheless, the results indicate that the costs arising from EDs are substantial.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22294558     DOI: 10.1002/eat.20977

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  41 in total

1.  The economic case for digital interventions for eating disorders among United States college students.

Authors:  Andrea E Kass; Katherine N Balantekin; Ellen E Fitzsimmons-Craft; Corinna Jacobi; Denise E Wilfley; C Barr Taylor
Journal:  Int J Eat Disord       Date:  2017-02-02       Impact factor: 4.861

Review 2.  The relationship between eating disorders and sexual trauma.

Authors:  Jennifer Madowitz; Brittany E Matheson; June Liang
Journal:  Eat Weight Disord       Date:  2015-05-15       Impact factor: 4.652

3.  The cost-effectiveness of school-based eating disorder screening.

Authors:  Davene R Wright; S Bryn Austin; H LeAnn Noh; Yushan Jiang; Kendrin R Sonneville
Journal:  Am J Public Health       Date:  2014-07-17       Impact factor: 9.308

4.  Cost-effectiveness of achieving clinical improvement with a dissonance-based eating disorder prevention program.

Authors:  Laura Akers; Paul Rohde; Eric Stice; Meghan L Butryn; Heather Shaw
Journal:  Eat Disord       Date:  2017-03-13       Impact factor: 3.222

Review 5.  Developing more efficient, effective, and disseminable treatments for eating disorders: an overview of the multiphase optimization strategy.

Authors:  Stephanie M Manasse; Kelsey E Clark; Adrienne S Juarascio; Evan M Forman
Journal:  Eat Weight Disord       Date:  2019-01-02       Impact factor: 4.652

6.  Cost analysis of inpatient treatment of anorexia nervosa in adolescents: hospital and caregiver perspectives.

Authors:  Alene Toulany; Matthew Wong; Debra K Katzman; Nadia Akseer; Cathleen Steinegger; Rebecca L Hancock-Howard; Peter C Coyte
Journal:  CMAJ Open       Date:  2015-04-02

Review 7.  Anorexia nervosa.

Authors:  Manuel Föcker; Susanne Knoll; Johannes Hebebrand
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-02       Impact factor: 4.785

Review 8.  Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature.

Authors:  Simon Frey; Carl R Blankart; Tom Stargardt
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

Review 9.  E-Health Interventions for Eating Disorders: Emerging Findings, Issues, and Opportunities.

Authors:  Jiska J Aardoom; Alexandra E Dingemans; Eric F Van Furth
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

10.  Interoceptive sensitivity deficits in women recovered from bulimia nervosa.

Authors:  Megan Klabunde; Dean T Acheson; Kerri N Boutelle; Scott C Matthews; Walter H Kaye
Journal:  Eat Behav       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.